AAA October 2020 – Page 22

MyoKardia causes Sanofi hearts to flutter

UK-based pharmaceuticals company Bristol-Myers Squibb has said it would acquire heart disease specialist MyoKardia for $13.1bn in cash, or $225 per share.

Published
Categorized as Comment